Anna Perdrix Rosell
Co-Founder at Sixfold Bioscience- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Sixfold Bioscience
-
United Kingdom
-
Biotechnology Research
-
1 - 100 Employee
-
Co-Founder
-
Mar 2017 - 6 years 10 months
Cambridge, United Kingdom Sixfold Bioscience is a venture-backed biotech startup developing next-generation delivery tools for RNA therapeutics (Y Combinator W18, Forbes 30 under 30 in Science & Healthcare 2017 and 2018).
-
-
-
Royal Academy of Engineering
-
United Kingdom
-
Non-profit Organizations
-
200 - 300 Employee
-
SME leader
-
Feb 2020 - 3 years 11 months
London, England, United Kingdom Supporting individuals in executive roles in high-growth engineering and technology SMEs to develop their leadership skills.
-
-
-
Newcastle University
-
United Kingdom
-
Higher Education
-
700 & Above Employee
-
Member Of The Board Of Advisors
-
Mar 2019 - 4 years 10 months
United Kingdom Portabolomics is a large consortium from the University of Newcastle working on cutting-edge synthetic biology at the interface of computational research and biological engineering. Funded by EPSRC (£4.4mn), it aims to build a standardised biological interface with applications in research laboratories and industrial settings.
-
-
-
Forbes
-
United States
-
Book and Periodical Publishing
-
700 & Above Employee
-
Forbes 30 Under 30
-
Jan 2018 - 6 years
-
-
-
The Francis Crick Institute
-
United Kingdom
-
Research Services
-
700 & Above Employee
-
PhD Candidate
-
2015 - 2019
London, United Kingdom Investigating the crosstalk between cancer cells and the tumour microenvironment in breast cancer and melanoma and its role in tumour aggressiveness.
-
-
-
King's College London
-
United Kingdom
-
Research Services
-
Research Associate
-
Apr 2015 - Sep 2015
Jeremy Carlton lab Identified a novel membrane-binding activity within an ESCRT-III subunit that is essential for post-mitotic nuclear regeneration.
-
-
-
Breast Cancer Now
-
United Kingdom
-
Non-profit Organizations
-
100 - 200 Employee
-
Research Associate
-
Feb 2014 - Apr 2015
Andrew Tutt and Anita Grigoriadis labs- Guy's Hospital London -Worked on target identification and validation of two drug targets for triple-negative breast cancer -Analysed gene expression data of germline BRCA1 wild-type and mutated tumours using the statistical R environment.
-
-
-
IFMSA | International Federation of Medical Students' Associations
-
Denmark
-
Non-profit Organization Management
-
100 - 200 Employee
-
Medical exchange internship
-
Jul 2013 - Aug 2013
Immunology department, University of Belgrade - Shortlisted as a candidate to attend the IFMSA medical exchanges. - Performed research on experimental autoimmune encephalomyelitis
-
-
-
IRB Barcelona
-
Spain
-
Research Services
-
300 - 400 Employee
-
Research Assistant
-
Nov 2012 - Jul 2013
Roger Gomis Lab -Biomarker identification for patients at higher risk of lung metastasis.
-
-
-
Oxitec
-
United Kingdom
-
Biotechnology Research
-
100 - 200 Employee
-
Research Intern
-
Jul 2012 - Aug 2012
Oxford, United Kingdom -Worked on identifying the best combination of different promoter and effector sequences in olive fly, Bactrocera oleae, in relation to induction of male sterility.
-
-
Education
-
Stanford University Graduate School of Business
Executive Leadership Development -
Quantic School of Business and Technology
Master of Business Administration - MBA -
Y Combinator
-
King's College London
Doctor of Philosophy (Ph.D.), Cancer Research -
Cambridge Judge Business School
Accelerate programme, Biotech Business Development -
King's College London
Master of Research, Translational Cancer Medicine -
Universitat de Barcelona
BsC Biomedical Sciences